France-based MedinCell Safety Study for Ivermectin: Three Decades of Safety

French biotech company MedinCell, tracked prior by TrialSite for its research into ivermectin, recently reported on the results of a comprehensive safety test evidencing that the drug ivermectin is safe.  Based on the analysis, the company declared there are no safety concerns anticipated that would preclude health authority review as a new indication for COVID-19. Authorized by a prominent toxicologist, the study included an extensive analysis of over 350 articles and reports from various medical and scientific journals. The company will submit the analysis for peer review to an internally acknowledged journal.